Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China flag China · Delayed Price · Currency is CNY
19.12
+0.45 (2.41%)
Feb 3, 2026, 3:00 PM CST

SHA:688553 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
975.281,085926.021,4901,8201,358
Other Revenue
9.019.011.063.273.446.55
984.291,094927.081,4931,8241,364
Revenue Growth (YoY)
-12.10%18.05%-37.92%-18.12%33.68%92.94%
Cost of Revenue
188.78187.58132.75180.12160.19120.91
Gross Profit
795.51906.8794.321,3131,6641,243
Selling, General & Admin
465.78511.56437.58810.82972.32771.98
Research & Development
334.32327.72340.76356.19248.2188.77
Other Operating Expenses
-5.196.576.727.839.575.34
Operating Expenses
794.7845.82787.931,1761,230865.56
Operating Income
0.860.986.39136.66433.49377.72
Interest Expense
-9.09-12.4-6.7-1.18-1.06-1.84
Interest & Investment Income
43.9650.2379.7391.1820.1613.4
Currency Exchange Gain (Loss)
-0.78-0.783.33-0.13-1.1-1.45
Other Non Operating Income (Expenses)
4.80.661.39-5.16-4.170.49
EBT Excluding Unusual Items
39.6998.6984.13221.37447.31388.32
Gain (Loss) on Sale of Investments
-36.65239.866.442.336.16-
Gain (Loss) on Sale of Assets
-0.41-0.3--0.03-0.02-0.82
Asset Writedown
-1.46-9.6----
Other Unusual Items
22.1921.0541.5814.7224.258.95
Pretax Income
23.36349.7132.15238.39477.7396.46
Income Tax Expense
-16.733.8-7.18-10.631.8454.63
Earnings From Continuing Operations
40.06315.9139.33248.99445.86341.82
Minority Interest in Earnings
7.179.490.45--1.5
Net Income
47.23325.39139.79248.99445.86343.32
Net Income to Common
47.23325.39139.79248.99445.86343.32
Net Income Growth
-83.02%132.78%-43.86%-44.16%29.87%94.03%
Shares Outstanding (Basic)
424423424422372361
Shares Outstanding (Diluted)
424423424422372361
Shares Change (YoY)
0.62%-0.24%0.37%13.58%2.81%-
EPS (Basic)
0.110.770.330.591.200.95
EPS (Diluted)
0.110.770.330.591.200.95
EPS Growth
-83.13%133.33%-44.07%-50.83%26.32%-
Free Cash Flow
12.14114.78-229.79-267.5512.91228.74
Free Cash Flow Per Share
0.030.27-0.54-0.630.040.63
Dividend Per Share
0.4630.4630.2130.2350.211-
Dividend Growth
117.47%117.47%-9.36%11.37%--
Gross Margin
80.82%82.86%85.68%87.94%91.22%91.14%
Operating Margin
0.08%5.57%0.69%9.15%23.77%27.69%
Profit Margin
4.80%29.73%15.08%16.67%24.45%25.17%
Free Cash Flow Margin
1.23%10.49%-24.79%-17.92%0.71%16.77%
EBITDA
90.59137.4965.2184.38468.91402.47
EBITDA Margin
9.20%12.56%7.03%12.35%25.71%29.50%
D&A For EBITDA
89.7876.5158.8147.7235.4324.75
EBIT
0.860.986.39136.66433.49377.72
EBIT Margin
0.08%5.57%0.69%9.15%23.77%27.69%
Effective Tax Rate
-9.67%--6.67%13.78%
Revenue as Reported
984.291,094927.081,4931,8241,364
Advertising Expenses
---13.713.81
Source: S&P Global Market Intelligence. Standard template. Financial Sources.